Literature DB >> 32399437

Synthetic Lethality Is a Novel and Potential Paradigm for Precision Medicine in Advanced Hepatocellular Carcinoma.

Mingyu Chen1,2, Xiujun Cai1,2.   

Abstract

Entities:  

Year:  2019        PMID： 32399437      PMCID： PMC7206588          DOI： 10.1159/000503927

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  5 in total

1.  Signalling: a new target for p53-null tumours.

Authors:  Isabel Lokody
Journal:  Nat Rev Cancer       Date:  2013-12-05       Impact factor: 60.716

2.  Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases.

Authors:  Jun-Xiang Zhang; Da-Qiang Li; Aiwu Ruth He; Mona Motwani; Vasilis Vasiliou; Jeyanthy Eswaran; Lopa Mishra; Rakesh Kumar
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

3.  Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.

Authors:  Cun Wang; Haojie Jin; Dongmei Gao; Cor Lieftink; Bastiaan Evers; Guangzhi Jin; Zheng Xue; Liqin Wang; Roderick L Beijersbergen; Wenxin Qin; René Bernards
Journal:  J Hepatol       Date:  2018-07-18       Impact factor: 25.083

Review 4.  Systemic Treatment for Advanced Hepatocellular Carcinoma.

Authors:  Mohamed Bouattour; Neil Mehta; Aiwu R He; Emil I Cohen; Jean-Charles Nault
Journal:  Liver Cancer       Date:  2019-03-06       Impact factor: 11.740

5.  ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.

Authors:  Chris T Williamson; Rowan Miller; Helen N Pemberton; Samuel E Jones; James Campbell; Asha Konde; Nicholas Badham; Rumana Rafiq; Rachel Brough; Aditi Gulati; Colm J Ryan; Jeff Francis; Peter B Vermulen; Andrew R Reynolds; Philip M Reaper; John R Pollard; Alan Ashworth; Christopher J Lord
Journal:  Nat Commun       Date:  2016-12-13       Impact factor: 14.919
  5 in total
  4 in total

Review 1.  Development of synthetic lethality in cancer: molecular and cellular classification.

Authors:  Shijie Li; Win Topatana; Sarun Juengpanich; Jiasheng Cao; Jiahao Hu; Bin Zhang; Diana Ma; Xiujun Cai; Mingyu Chen
Journal:  Signal Transduct Target Ther       Date:  2020-10-19

2.  Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma.

Authors:  Qifan Zhang; Zhen Xiao; Shibo Sun; Kai Wang; Jianping Qian; Zhonglin Cui; Tao Tao; Jie Zhou
Journal:  Cancer Manag Res       Date:  2021-03-11       Impact factor: 3.989

3.  Bioinformatics Analysis Using ATAC-seq and RNA-seq for the Identification of 15 Gene Signatures Associated With the Prediction of Prognosis in Hepatocellular Carcinoma.

Authors:  Hui Yang; Gang Li; Guangping Qiu
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244

4.  Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer.

Authors:  Sang-Hyeon Ju; Seong Eun Lee; Yea Eun Kang; Minho Shong
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.